Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 14, Number 6—June 2008

Letter

Inquilinus limosus and Cystic Fibrosis

Fadi Bittar*, Anne Leydier†, Emmanuelle Bosdure†, Alexandre Toro*, Martine Reynaud-Gaubert‡, Stéphanie Boniface‡, Nathalie Stremler†, Jean-Christophe Dubus†, Jacques Sarles†, Didier Raoult*, and Jean-Marc Rolain*Comments to Author 
Author affiliations: *Université de la Méditerranée, Marseille, France; †Hôpital Timone, Marseille, France; ‡Hôpital Sainte Marguerite, Marseille, France;

Main Article

Table

Clinical and epidemiologic features of cystic fibrosis (CF) patients with Inquilinus limosus*

Case no. Age, y/sex Lung transplant Positive samples Clinical manifestation (first isolation) Growth on MacConkey agar Growth on selective agar (d) Phenotypic identification† Other associated pathogens Reference
1 22/F Yes Lung explant, BAL, sputum Pneumonia Poor ND AR PA, PM (1)
2 17/M No Sputum Stable No Yes (6 d) SP SA, PA, CA (3)
3 14/F No Sputum Stable No Yes (5 d) SP PA, AF, CA (3)
4 12/M No Sputum Stable ND Yes (ND) SP PA, SM, SA, AX (5)
5 13/F No Sputum Exacerbation ND Yes (ND) SP PA, SA, AF (5)
6 8/M No Sputum Stable ND Yes (ND) SP PA (5)
7 10/M No Sputum Stable ND Yes (ND) SP None (5)
8 18/M No Sputum Exacerbation ND Yes (ND) AR PA, SA, AF (5)
9 16/F No Sputum Severe exacerbation ND ND PA PA (4)
10 19/M No Sputum Stable ND ND ND PA (4)
11 17/F No Sputum Exacerbation ND ND ND PA, CA, AF (4)
12 20/F No Sputum Exacerbation ND ND ND PA, SA, CA, AF (4)
13 17/F No Sputum Stable ND ND ND PA, SA, SM, CA, AF (4)
14 35/M No Sputum Respiratory decline ND ND PA PA, SM, SMA (4)
15 17/F No Sputum Stable No Yes (4 d) SP CA This study
16 2/M No Sputum Productive cough No Yes (3 d) SP SA, HI This study
17 21/M No Sputum Exacerbation No Yes (3 d) AR PA, AF This study
18 15/M No Sputum Fever and thoracic pain No Yes (3 d) AR SA This study

*BAL, bronchoalveolar lavage; ND, not determined; AR, Agrobacterium radiobacter; PA, Pseudomonas aeruginosa; PM, Proteus mirabilis; SP, Sphingomonas paucimobilis; SA, Staphylococcus aureus; CA, Candida albicans; AF, Aspergillus fumigatus; SM, Stenotrophomonas maltophilia; AX, Achromobacter xylosoxidans; SMA, Serratia marcescens; HI, Haemophilus influenzae.
†Phenotypic identification was obtained by using the BIOLOG GN MicroPlate assay (BIOLOG Inc., Hayward, CA, USA) for case 1 and the API 20NE kit system (bioMérieux, Marcy l’Etoile, France) for cases 2–8 and 15–18.

Main Article

TOP